EE200200417A - 6-(4-klorofenüül)-2,2-dimetüül-7-fenüül-2,3-dihüdro-1H-pürrolisiin-5-üüläädikhappe valmistamisprotsess - Google Patents

6-(4-klorofenüül)-2,2-dimetüül-7-fenüül-2,3-dihüdro-1H-pürrolisiin-5-üüläädikhappe valmistamisprotsess

Info

Publication number
EE200200417A
EE200200417A EEP200200417A EEP200200417A EE200200417A EE 200200417 A EE200200417 A EE 200200417A EE P200200417 A EEP200200417 A EE P200200417A EE P200200417 A EEP200200417 A EE P200200417A EE 200200417 A EE200200417 A EE 200200417A
Authority
EE
Estonia
Prior art keywords
compound
preparation
formula
pyrrolizin
chlorophenyl
Prior art date
Application number
EEP200200417A
Other languages
English (en)
Inventor
Kammermeier Thomas
Laufer Stefan
Merckle Philipp
Striegel Hans-G�nter
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MXPA/A/2000/001047A external-priority patent/MXPA00001047A/xx
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Publication of EE200200417A publication Critical patent/EE200200417A/et
Publication of EE05125B1 publication Critical patent/EE05125B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP200200417A 2000-01-28 2001-01-26 6-(4-klorofenl)-2,2-dimetl-7-fenl-2,3-dihdro-1H-prrolisiin-5-l„„dikhappe valmistamismeetod EE05125B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXPA/A/2000/001047A MXPA00001047A (en) 2000-01-28 Method for producing 6-(4-chlorophenyl) -2,2-dimethyl-7- phenyl -2,3-dihydro- 1h-pyrrolizine- 5-yl acetic acid
PCT/EP2001/000852 WO2001055149A1 (de) 2000-01-28 2001-01-26 Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl-essigsäure

Publications (2)

Publication Number Publication Date
EE200200417A true EE200200417A (et) 2003-12-15
EE05125B1 EE05125B1 (et) 2009-02-16

Family

ID=32589023

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200417A EE05125B1 (et) 2000-01-28 2001-01-26 6-(4-klorofenl)-2,2-dimetl-7-fenl-2,3-dihdro-1H-prrolisiin-5-l„„dikhappe valmistamismeetod

Country Status (30)

Country Link
US (1) US6417371B1 (et)
EP (1) EP1252164B1 (et)
JP (1) JP5143326B2 (et)
KR (1) KR100749222B1 (et)
CN (1) CN1160357C (et)
AT (1) ATE262529T1 (et)
AU (1) AU779616B2 (et)
BG (1) BG65567B1 (et)
BR (1) BR0107898A (et)
CA (1) CA2397767C (et)
CU (1) CU23193A3 (et)
DE (1) DE50101761D1 (et)
DK (1) DK1252164T3 (et)
EA (1) EA004938B1 (et)
EE (1) EE05125B1 (et)
ES (1) ES2218382T3 (et)
GE (1) GEP20043408B (et)
HR (1) HRP20020707B1 (et)
HU (1) HUP0300604A3 (et)
IS (1) IS2404B (et)
NZ (1) NZ520429A (et)
PL (1) PL208027B1 (et)
PT (1) PT1252164E (et)
RS (1) RS50374B (et)
SK (1) SK286608B6 (et)
TR (1) TR200400691T4 (et)
TW (1) TWI289561B (et)
UA (1) UA72580C2 (et)
WO (1) WO2001055149A1 (et)
ZA (1) ZA200206832B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141285A1 (de) * 2001-08-23 2003-03-27 Merckle Gmbh Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
DE102005012971A1 (de) * 2005-03-21 2006-09-28 Merckle Gmbh Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
WO2007108006A1 (en) * 2006-03-23 2007-09-27 Unichem Laboratories Limited Process for the preparation of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2, 3-dihydro-1h-pyrrolizin-5-yl acetic acid and its intermediates
PT2350082E (pt) * 2008-10-31 2015-04-30 C A I R Biosciences Gmbh Sal de colina e trometamina de licofelona
WO2017015013A1 (en) * 2015-07-17 2017-01-26 The Board Of Regents Of The University Of Oklahoma Licofelone derivatives and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3915450A1 (de) * 1989-05-11 1990-11-15 Gerd Prof Dr Dannhardt Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
US5260451A (en) 1989-05-11 1993-11-09 Merckle Gmbh Substituted pyrrole compounds and use thereof in pharmaceutical compositions
DE4419315A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419247A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
DE4419246A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie

Also Published As

Publication number Publication date
JP5143326B2 (ja) 2013-02-13
EP1252164B1 (de) 2004-03-24
ZA200206832B (en) 2003-10-07
HUP0300604A2 (hu) 2003-07-28
ES2218382T3 (es) 2004-11-16
WO2001055149A1 (de) 2001-08-02
AU3371101A (en) 2001-08-07
YU56502A (sh) 2005-06-10
KR20020075895A (ko) 2002-10-07
IS6475A (is) 2002-07-19
SK10432002A3 (sk) 2003-02-04
CU23193A3 (es) 2007-03-23
BG106951A (en) 2003-07-31
KR100749222B1 (ko) 2007-08-13
IS2404B (is) 2008-09-15
HK1047590A1 (en) 2003-02-28
HRP20020707B1 (en) 2006-05-31
DE50101761D1 (de) 2004-04-29
CN1160357C (zh) 2004-08-04
BG65567B1 (bg) 2008-12-30
UA72580C2 (en) 2005-03-15
DK1252164T3 (da) 2004-07-05
CN1396922A (zh) 2003-02-12
CA2397767C (en) 2008-05-06
NZ520429A (en) 2003-08-29
TWI289561B (en) 2007-11-11
EA004938B1 (ru) 2004-10-28
HUP0300604A3 (en) 2003-10-28
JP2004517799A (ja) 2004-06-17
SK286608B6 (sk) 2009-02-05
GEP20043408B (en) 2004-06-10
ATE262529T1 (de) 2004-04-15
HRP20020707A2 (en) 2004-12-31
US6417371B1 (en) 2002-07-09
PL208027B1 (pl) 2011-03-31
BR0107898A (pt) 2002-11-05
US20020028953A1 (en) 2002-03-07
TR200400691T4 (tr) 2004-11-22
RS50374B (sr) 2009-11-10
CA2397767A1 (en) 2001-08-02
AU779616B2 (en) 2005-02-03
PL356774A1 (en) 2004-07-12
EP1252164A1 (de) 2002-10-30
EA200200740A1 (ru) 2002-12-26
PT1252164E (pt) 2004-08-31
EE05125B1 (et) 2009-02-16

Similar Documents

Publication Publication Date Title
UA82980C2 (ru) Замещенные амиды бензойной кислоты и их применение для угнетения ангиогенеза
NO20034526L (no) Nye fremgangsmater for fremstilling av oksabispiner
EE05125B1 (et) 6-(4-klorofenl)-2,2-dimetl-7-fenl-2,3-dihdro-1H-prrolisiin-5-l„„dikhappe valmistamismeetod
MY128460A (en) Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
ATE329900T1 (de) Verfahren zur herstellung von 2-pyrrolidon
WO2001081298A3 (en) Cyclic carboxylic acids as integrin antagonists
CN105541688B (zh) 一种合成高浓度无水过氧乙酸溶液联产乙酰脲的方法
ATE545636T1 (de) Synthese von cyclenderivaten
PY0109408A (es) Proceso para preparar acido 6-(4-clorofenil)-2,2-dimetil-7-fenil-2,3-dihidro-1 h 0 pirrolizin-5-ilacetico
NZ530173A (en) Method for producing an essentially chlorite-free, stable, aqueous chlorine-oxygen solution, the chlorine-oxygen solution obtained by means of said method, and the use of the same
DE50106283D1 (de) Herstellung der 2-Oxo-1,3-dibenzyl-cis-4,5-imidazolidindicarbonsäure bzw. ihres Anhydrids
UY26708A1 (es) Proceso para preparar ácido 6 - (4 - clorofenil) - 2, 2 - dimetil - 7 - fenil - 2, 3 - dihidro - 1 h - pirrolizin - 5 - ilacético.
EP1798235A4 (en) ACIDIC ACID SALT OF IRINOTECAN
EP1765350A4 (en) METHOD OF MANUFACTURING A SOLID DISPERSION WITH ITRACONAZOLE
HUP9902375A2 (hu) Eljárás 2-metoxi-4(N-t-butilamino-karbonil)-benzolszulfoklorid előállítására
CO5280193A1 (es) Proceso para preparar acido 6-(4-clorofenil)-2,2-dimetil-7- fenil-2,3-dihidro-1h-pirrolizin-5-il acetico
MD2639G2 (ro) Procedeu de obţinere a 12-hidroperoxi-8a,12-epoxi-11-bishomodrimanului din 11-bishomodriman-8a-ol-12-onă
UA87995C2 (ru) Способ получения высокочистого свободного от галогенов о-фталальдегида
EG25330A (en) Preparation of lactams.
DK1073625T3 (da) Tilidinmesylat, fremgangsmåder til dets fremstilling og et farmaceutisk præparat deraf
ATE506349T1 (de) Verfahren zur herstellung von 7-chinolinyl-3,5- dihydroxyhept-6-enoat
UA132497U (uk) Спосіб одержання каталізатора для синтезу вуглецевих нанотрубок
KR970006287A (ko) 개선된 바비튜르산의 제조방법
JP2006045123A (ja) ４−ヒドロキシ−２−メチルチオピリミジンの製造方法
KR970042509A (ko) 2, 6-디클로로-5-플루오로니코틴산의 제조방법

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20130126